Carneiro, Benedito A.
El-Deiry, Wafik S. http://orcid.org/0000-0002-9577-8266
Article History
Accepted: 6 February 2020
First Online: 23 March 2020
Competing interests
: B.A.C. has received funding for clinical trials from AbbVie, Actuate Therapeutics, Astellas, AstraZeneca, Bayer and MedImmune. W.S.E-D. is the scientific founder and a shareholder of Oncoceutics and p53-Therapeutics, and has received support for clinical trials from Bayer, BMS and Genentech.